Insider Stock Trading History of Lim Jonathan E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lim Jonathan E since year 2005. The trader's CIK number is 1283290. At the time of this reporting, Lim Jonathan E is the President, CEO & Director of Ignyta, Inc. . (stock ticker symbol RXDX). See this page for all insider trading activities at Ignyta, Inc. .

Note that in the past Lim Jonathan E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lim Jonathan E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-13 RXDX Ignyta, Inc. Option Ex 6,945 .60 4,167
2016-04-11 RXDX Ignyta, Inc. Option Ex 26,388 .60 15,832
2016-03-17 RXDX Ignyta, Inc. Buy 24,852 5.51 136,884
2015-08-19 RXDX Ignyta, Inc. Buy 6,740 13.00 87,626
2015-08-20 RXDX Ignyta, Inc. Buy 1,740 12.73 22,148
2015-03-20 RXDX Ignyta, Inc. Buy 20,000 9.01 180,200
2014-08-15 RXDX Ignyta, Inc. Buy 5,000 7.60 37,995
2010-01-12 HALO Halozyme Therapeutics Inc Option Ex 30,000 .39 11,700
2008-03-20 HALO Halozyme Therapeutics Inc Sale 250,000 6.06 1,515,000
2008-03-19 HALO Halozyme Therapeutics Inc Option Ex 230,000 .39 89,700
2007-11-30 HALO Halozyme Therapeutics Inc Option Ex 20,000 .39 7,800
2007-11-30 HALO Halozyme Therapeutics Inc Sale 20,000 8.22 164,400
2007-10-31 HALO Halozyme Therapeutics Inc Option Ex 25,000 .39 9,750
2007-10-31 HALO Halozyme Therapeutics Inc Sale 25,000 9.06 226,625
2007-10-16 HALO Halozyme Therapeutics Inc Option Ex 26,690 .45 11,983
2007-09-28 HALO Halozyme Therapeutics Inc Option Ex 25,000 .39 9,750
2007-09-28 HALO Halozyme Therapeutics Inc Sale 25,000 8.77 219,300
2007-08-31 HALO Halozyme Therapeutics Inc Option Ex 25,000 .39 9,750
2007-08-31 HALO Halozyme Therapeutics Inc Sale 12,200 8.53 104,017
2007-08-31 HALO Halozyme Therapeutics Inc Sale 12,800 8.83 113,036
2007-07-31 HALO Halozyme Therapeutics Inc Option Ex 20,000 .39 7,800
2007-07-31 HALO Halozyme Therapeutics Inc Sale 20,000 8.23 164,700
2007-06-29 HALO Halozyme Therapeutics Inc Sale 8,199 9.58 78,562
2007-06-29 HALO Halozyme Therapeutics Inc Sale 16,801 9.38 157,643
2007-06-29 HALO Halozyme Therapeutics Inc Option Ex 25,000 .39 9,750
2007-06-25 HALO Halozyme Therapeutics Inc Option Ex 96,313 .39 37,562
2007-05-31 HALO Halozyme Therapeutics Inc Option Ex 12,500 .39 4,875
2007-05-31 HALO Halozyme Therapeutics Inc Sale 19,100 10.35 197,723
2007-05-31 HALO Halozyme Therapeutics Inc Sale 5,900 10.61 62,599

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lim Jonathan E (President, CEO & Director of Ignyta, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.